Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Certain Dibenzo derivatives may help treat prostate cancer.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Chromosomal differences affect how muscle cells respond to testosterone.

The herbal mixture could potentially improve hair loss.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Exercise and finasteride together improve ovary health in PCOS rats.

High androgen levels in young women with PCOS are linked to higher blood pressure.

The document concludes that hair biology is complex and there are still unanswered questions about hair loss and follicle changes.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Moxibustion may help improve ovarian function by changing androgen levels.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

Men with testicular cancer were less likely to experience baldness and severe acne.